I2Pure Iodine Breakthrough Sparks Deal Flow
Drs. Meehan & Johnston back I2Pure’s molecular iodine. ✅ Use this trigger to pitch non-antibiotic infection prevention. Next touch: book the demo and boost your pipeline.
Published on
Do not index
Do not index
🚀 Battle Card
🚀 Battle Card: I2Pure
Quick trigger:
👤 Decision Maker in the News
- Dr. John Meehan, Medical Advisor · 🔗 LinkedIn
- Dr. Peter Johnston, Medical Advisor · 🔗 LinkedIn
💡 Why It Matters
- Top-tier clinical research on iodine formulations drives faster adoption of non-toxic infection prevention protocols. → Source
- This I2Pure sales trigger underscores the urgency of scalable, antibiotic-alternative solutions in surgery.
🎯 Core Pain Point
- Lack of validated surgical infection prevention tools in healthcare settings
- Critical need to combat antibiotic resistance with non-antibiotic antimicrobials
💰 What to Pitch
- Primary: Molecular iodine solutions → Reduce surgical site infections
- Expansion: Research partnership and clinical validation support → Accelerate product adoption and evidence generation
🗺️ Quick Context
- HQ: Ashburn, VA
- Employees: ≈ 30
- Rev: ≈ $5 M
- Website: i2pure.com
🤼 Competitive Intel
*Which other vendors you’ll probably face to win I2Pure’s business in sales and marketing tech.*
- Salesforce — CRM / Sales Cloud
- Unique edge: End-to-end sales pipeline management
- Evaluated by VP Sales & COO for enterprise scalability
- HubSpot — CRM / Marketing Automation
- Unique edge: Integrated inbound marketing tools
- Evaluated by CMO & Dir. Marketing for content-driven lead gen
- Marketo — Marketing Automation
- Unique edge: Advanced campaign orchestration
- Evaluated by Dir. Marketing for trade show and event engagement
- Pardot — Marketing Automation
- Unique edge: Native Salesforce integration
- Evaluated by VP Sales for lead scoring alignment
- Outreach — Sales Engagement
- Unique edge: Automated multichannel sequences
- Evaluated by Sales Ops for improving touch frequency
✅ Do-Now Checklist
Connect with Dr. Meehan & Dr. Johnston on LinkedIn (links above)
Drop first-touch email referencing the I2Pure sales trigger and schedule a demo
Log follow-ups in CRM for Days 3 & 10 and tag “I2Pure sales trigger”
Next Step
🧠 Copy My Prompt for Personalized Cold Outreach
────────────────────────────
✏️ YOUR COMPANY
────────────────────────────
OUR_COMPANY = ❑≈ TBD❑
OFFER_BRIEF = ❑Non-toxic molecular iodine infection prevention solutions❑
PROOF_METRIC = ❑≈ TBD❑
CTA_STYLE = ❑quick_call❑
TONE = ❑friendly❑
────────────────────────────
📌 TARGET COMPANY
────────────────────────────
NAME = ≈ TBD
COMPANY = I2Pure
DEPT = ≈ TBD
SIZE = ≈ TBD
BOTTLENECK = ≈ TBD
EVENT = ≈ Celebrating achievements of Medical Advisors
DETAIL = ≈ Celebrating achievements of Dr. John Meehan and Dr. Peter Johnston
PAIN = Lack of validated surgical infection prevention tools in healthcare settings
SRC = http://cts.businesswire.com/ct/CT?id=ftfLlWd9aZbF2NXfwppam3Bd664=&newsLang=en&newsId=20250916875066&div=41152219
SIM_CO = ≈ TBD
WIN_METRIC = ≈ TBD
NEXT_SIZE = ≈ TBD
EMP_EST = ≈ 30
REV_EST = ≈ $5M
────────────────────────
TASK FOR CHATGPT
────────────────────────
Role: “NewsletterForLeads SDR-Assist”.
Validate any ≈ guesses via SRC.
EMAIL (keep breaks):
Subject: ≈ TBD-person ≈ TBD
≈ TBD—noticed your ≈ TBD team is ≈ TBD.
That’s when ≈ TBD slows growth.
We helped ≈ TBD fix this with Non-toxic molecular iodine infection prevention solutions.
Result: ≈ TBD.
Quick call?
PS—next bottleneck hits ≈ TBD.
DM ≤45 words, TONE:
Saw your post about Celebrating achievements of Dr. John Meehan and Dr. Peter Johnston — Lack of validated surgical infection prevention tools in healthcare settings.
Non-toxic molecular iodine infection prevention solutions. ≈ TBD.
Quick chat?